Compounds > pyrazolanthrone
Page last updated: 2024-08-18

pyrazolanthrone and Ovarian Neoplasms

pyrazolanthrone has been researched along with Ovarian Neoplasms in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's9 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aghaei, M; Ghasemi, A; Hashemy, SI; Panjehpour, M1
Akin, N; Arvas, M; Bildik, G; Esmalian, Y; Guzel, Y; Ince, U; Karahuseyinoglu, S; Oktem, O; Palaoglu, E; Sahin, GN; Senbabaoglu, F; Taskiran, C; Urman, D; Yakin, K1
Lin, R; Si, L; Yang, R; Yang, S1
Chen, X; Chen, Y; Hou, X; Lin, X; Su, S; Tian, Y; Zhang, Q1
Kitanaka, C; Kurachi, H; Ohta, T; Okada, M; Seino, M; Seino, S; Shibuya, K; Suzuki, S1
Kitanaka, C; Kurachi, H; Kuramoto, K; Nagase, S; Ohta, T; Okada, M; Sakaki, H; Seino, M; Seino, S; Suzuki, S; Takeda, H; Watarai, H1
Chen, TC; Chen, YC; Chien, CC; Wu, MS1
Pang, X; Shang, H; Zhang, S; Zhang, Y; Zhao, Y1
Chan, DW; Chiu, P; Liu, VW; Ngan, HY; Wang, Y1
Chang, HL; Dombkowski, D; Donahoe, PK; MacLaughlin, DT; Meirelles, K; Mueller, PR; Pieretti-Vanmarcke, R; Preffer, FI; Szotek, PP; Teixeira, J; Wei, X1
Atkinson, S; Bilsland, AE; Keith, WN; Kolch, W; Stevenson, K1
Donahoe, PK; O'Neill, FH; Pieretti-Vanmarcke, R; Renlund, N; Teixeira, J; Zhang, L1

Other Studies

12 other study(ies) available for pyrazolanthrone and Ovarian Neoplasms

ArticleYear
Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways.
    Journal of cellular biochemistry, 2018, Volume: 119, Issue:2

    Topics: Anthracenes; Cell Line, Tumor; Cell Movement; Female; Flavonoids; Gene Knockdown Techniques; Humans; Leptin; MAP Kinase Signaling System; Matrix Metalloproteinase 7; Neoplasm Invasiveness; Ovarian Neoplasms

2018
Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
    Cell death & disease, 2018, 04-01, Volume: 9, Issue:4

    Topics: Acetonitriles; Animals; Anthracenes; Anti-Mullerian Hormone; Apoptosis; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Estradiol; Female; G2 Phase Cell Cycle Checkpoints; Granulosa Cell Tumor; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, SCID; Mitosis; Ovarian Neoplasms; RNA Interference; RNA, Small Interfering; Signal Transduction

2018
Piperine functions as a tumor suppressor for human ovarian tumor growth via activation of JNK/p38 MAPK-mediated intrinsic apoptotic pathway.
    Bioscience reports, 2018, 06-29, Volume: 38, Issue:3

    Topics: Alkaloids; Anthracenes; Apoptosis; Benzodioxoles; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Proliferation; Cell Survival; Female; Humans; Imidazoles; MAP Kinase Kinase 4; Oligopeptides; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Piperidines; Polyunsaturated Alkamides; Pyridines; Tumor Suppressor Proteins

2018
The Drug Combination of SB202190 and SP600125 Significantly Inhibit the Growth and Metastasis of Olaparib-resistant Ovarian Cancer Cell.
    Current pharmaceutical biotechnology, 2018, Volume: 19, Issue:6

    Topics: Animals; Anthracenes; Autophagy; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Female; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phthalazines; Piperazines; Protein Kinase Inhibitors; Pyridines

2018
Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.
    Anticancer research, 2014, Volume: 34, Issue:9

    Topics: Animals; Anthracenes; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Enzyme Activation; Female; Gene Knockdown Techniques; Heterografts; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Neoplastic Stem Cells; Ovarian Neoplasms; Signal Transduction; Spheroids, Cellular; Tumor Burden; Tumor Cells, Cultured

2014
Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel.
    Oncology reports, 2016, Volume: 35, Issue:1

    Topics: Anthracenes; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Ovarian Neoplasms; Paclitaxel

2016
Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2016, Jan-15, Volume: 23, Issue:1

    Topics: Adenine; Anthracenes; Apoptosis; Caspase 3; Cell Line, Tumor; eIF-2 Kinase; Evodia; Female; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Membrane Potential, Mitochondrial; Ovarian Neoplasms; Poly(ADP-ribose) Polymerases; Quinazolines; Signal Transduction; Structure-Activity Relationship

2016
Basic fibroblast growth factor upregulates adrenomedullin expression in ovarian epithelial carcinoma cells via JNK-AP-1 pathway.
    Regulatory peptides, 2009, Oct-09, Volume: 157, Issue:1-3

    Topics: Adrenomedullin; Adult; Aged; Anthracenes; Female; Fibroblast Growth Factor 2; Humans; JNK Mitogen-Activated Protein Kinases; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; RNA, Messenger; Transcription Factor AP-1; Tumor Cells, Cultured; Up-Regulation

2009
Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, May-01, Volume: 16, Issue:9

    Topics: Alternative Splicing; Anthracenes; Blotting, Western; Butadienes; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; GRB7 Adaptor Protein; Green Fluorescent Proteins; Humans; Immunohistochemistry; Microscopy, Confocal; Middle Aged; Mitogen-Activated Protein Kinases; Neoplasm Staging; Nitriles; Ovarian Neoplasms; Protein Isoforms; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transfection

2010
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Nov-02, Volume: 107, Issue:44

    Topics: Anthracenes; Anti-Mullerian Hormone; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; CD24 Antigen; Cell Adhesion Molecules; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Epithelial Cell Adhesion Molecule; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Neoplastic Stem Cells; Ovarian Neoplasms

2010
Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3.
    Cancer research, 2006, Feb-01, Volume: 66, Issue:3

    Topics: Anthracenes; Binding Sites; Cell Line, Tumor; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 1; Ovarian Neoplasms; Promoter Regions, Genetic; RNA; Sp1 Transcription Factor; Sp3 Transcription Factor; Telomerase; Transcriptional Activation; Transfection

2006
c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction.
    Endocrinology, 2008, Volume: 149, Issue:1

    Topics: Animals; Anthracenes; Anti-Mullerian Hormone; Bone Morphogenetic Proteins; Cell Proliferation; Cells, Cultured; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Female; JNK Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Promoter Regions, Genetic; Receptors, Peptide; Receptors, Transforming Growth Factor beta; Signal Transduction

2008